Hyper-inflammation is a hallmark of COVID-19 and is characterized by high levels of circulating proinflammatory cytokines, including interleukin-6 (IL-6), interferon-γ (IFN-γ), IL-1β, tumor necrosis factor (TNF), acute-phase reactants, and ferritin. This evidence concerns the gene IL1B and COVID-19.